Two leaders in research and biopharma manufacturing enter a strategic collaboration to meet customer need for a simplified, faster development process
Chalfont St. Giles, UK and Plankstadt, Germany - June 28, 2017 - CordenPharma International and GE Healthcare’s Dharmacon business have entered a strategic collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.